ProCE Banner Activity

Expert Pharmacists Answer Audience Questions on CAR T-Cell Therapy

Clinical Thought

Two expert pharmacists answer audience questions from a live symposium on optimal current use of CAR T-cell therapies in patients with cancer.

Released: April 15, 2022

Expiration: April 14, 2023

Share

Faculty

Craig Freyer

Craig Freyer, PharmD, BCOP

Clinical Pharmacy Specialist
Hematology/Oncology, Stem Cell Transplant, and Cellular Therapy
Department of Pharmacy
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania

Andrew Lin

Andrew Lin, PharmD, BCOP

Clinical Pharmacy Specialist
Adult Bone Marrow Transplant Service
Memorial Sloan Kettering Cancer Center
New York, New York

Provided by

Provided by ProCE, LLC

ProCE Banner

Supporters

Supported by an educational grant from

Bristol Myers Squibb

Faculty Disclosure

Primary Author

Craig Freyer, PharmD, BCOP

Clinical Pharmacy Specialist
Hematology/Oncology, Stem Cell Transplant, and Cellular Therapy
Department of Pharmacy
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania

Craig W. Freyer, PharmD, BCOP, has disclosed that he has received consulting fees from Astellas, EUSA, and Servier.

Andrew Lin, PharmD, BCOP

Clinical Pharmacy Specialist
Adult Bone Marrow Transplant Service
Memorial Sloan Kettering Cancer Center
New York, New York

Andrew Lin, PharmD, BCOP, has disclosed that he has received consulting fees from EUSA, Incyte, and Medexus.